Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction

ARSLAN A., Ozaydin M. , AKSOY F. , ARSLAN B., BAS H. A. , ERDOGAN D., ...Daha Fazla

MEDICINA-LITHUANIA, cilt.52, ss.104-109, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 52 Konu: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.medici.2016.02.006
  • Sayfa Sayıları: ss.104-109


Background and aim: Atrial fibrillation (AF) is the most common supraventricular arrhythmia following ST-segment elevation myocardial infarction (STEMI). We evaluated the association between use of previous angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers (renin-angiotensin system [RAS] blockers) and started RAS blockers after MI and development of AF in patients presenting with acute STEMI.